Found: 16
Select item for more details and to access through your institution.
High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 8, p. 973, doi. 10.1111/apt.17909
- By:
- Publication type:
- Article
A risk prediction model for hepatocellular carcinoma in non‐alcoholic fatty liver disease without cirrhosis.
- Published in:
- Liver International, 2024, v. 44, n. 3, p. 738, doi. 10.1111/liv.15819
- By:
- Publication type:
- Article
Prognosis of Patients with Chronic Hepatitis C Genotype 1b Infection Treated Using Daclatasvir/Asunaprevir after Sustained Virologic Response: A 6-Year Multicenter Prospective Observational Study.
- Published in:
- Medicina (1010660X), 2023, v. 59, n. 8, p. 1436, doi. 10.3390/medicina59081436
- By:
- Publication type:
- Article
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ALS-L1023 in Non-Alcoholic Fatty Liver Disease.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 4, p. 623, doi. 10.3390/ph16040623
- By:
- Publication type:
- Article
Non‐alcoholic fatty liver disease and the risk of dementia—Authors' reply.
- Published in:
- Liver International, 2022, v. 42, n. 8, p. 1914, doi. 10.1111/liv.15332
- By:
- Publication type:
- Article
Association between non‐alcoholic fatty liver disease and the risk of dementia: A nationwide cohort study.
- Published in:
- Liver International, 2022, v. 42, n. 5, p. 1027, doi. 10.1111/liv.15244
- By:
- Publication type:
- Article
Multiple imputation analysis for propensity score matching with missing causes of failure: An application to hepatocellular carcinoma data.
- Published in:
- Statistical Methods in Medical Research, 2021, v. 30, n. 10, p. 2313, doi. 10.1177/09622802211037075
- By:
- Publication type:
- Article
Tenofovir disoproxil fumarate on the risk of hepatocellular carcinoma in chronic hepatitis B patients with failure to preceding treatments: A nationwide cohort study.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 8, p. 1150, doi. 10.1111/jvh.13530
- By:
- Publication type:
- Article
Letter: serum hepatitis B virus DNA and risk of hepatocellular carcinoma in patients with chronic hepatitis B—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 6, p. 763, doi. 10.1111/apt.16278
- By:
- Publication type:
- Article
Reduced liver cancer mortality with regular clinic follow‐up among patients with chronic hepatitis B: A nationwide cohort study.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 20, p. 7781, doi. 10.1002/cam4.3421
- By:
- Publication type:
- Article
Letter: moderate levels of serum hepatitis B virus DNA alone are not associated with increased risk of hepatocellular carcinoma in chronic hepatitis B patients. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 3, p. 576, doi. 10.1111/apt.15881
- By:
- Publication type:
- Article
Editorial: hepatitis B DNA thresholds and risk of hepatocellular carcinoma: different number patterns in HBeAg‐positive versus HBeAg‐negative patients. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1440, doi. 10.1111/apt.15794
- By:
- Publication type:
- Article
Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 11, p. 1169, doi. 10.1111/apt.15725
- By:
- Publication type:
- Article
High risk of clinical events in untreated HBeAg‐negative chronic hepatitis B patients with high viral load and no significant ALT elevation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 2, p. 215, doi. 10.1111/apt.15311
- By:
- Publication type:
- Article
Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Reappraisal of serum alpha-foetoprotein as a surveillance test for hepatocellular carcinoma during entecavir treatment.
- Published in:
- Liver International, 2015, v. 35, n. 1, p. 232, doi. 10.1111/liv.12516
- By:
- Publication type:
- Article